InfoStrength Creates Project Synergies for Clinical Trial Services

InfoStrength, Inc., a leader of regulatory-compliant IT business strategies and collaboration tools, recently signed a software applications development deal with Clinical Trial Services (CTS), an international firm specializing in the preparation and management of clinical trial supplies for leading pharmaceutical and biotech companies.

Raleigh, NC (PRWEB) January 9 2004--InfoStrength, Inc., a leader of regulatory-compliant IT business strategies and collaboration tools, recently signed a software applications development deal with Clinical Trial Services (CTS), an international firm specializing in the preparation and management of clinical trial supplies for leading pharmaceutical and biotech companies.

We are excited to have been selected to work with CTS on this project. This is a dynamic collaborative effort that highlights InfoStrengths 21CFR Part 11 expertise, our established software methodology, and our creative project management approach using the InfoStrength Smart Enterprise Suite." said Rita Geiger, President and CEO. InfoStrength will manage the project utilizing its highly-skilled design and development team and its web-based collaboration tool, the InfoStrength Smart Enterprise Suite (SES). Clinical Trial Services will contribute valuable resources to the project from their offices in North Carolina, Pennsylvania, and the United Kingdom.

Says Robert Dunlop, CEO of CTS, The InfoStrength SES has already produced benefits for CTS by creating synergy and accountability among the team members. Our managers and stakeholders located in multiple offices throughout the US and Europe have the ability to track project progress with easy to use, and yet extensive reporting capability. Simultaneously, individual team members are able to collaborate with each other and each team member can quickly assess their responsibilities and the interdependencies of concurrent activities, document their project deliverables, and instantly share deliverables with the rest of the team in a secure environment regardless of their location."

The InfoStrength SES is a web-based modular and configurable suite of applications that enables companies to establish an environment of collaboration and teamwork delivering process management, project management, partner management, and client management functionality. The entire team, from application developer to executive management, is actively engaged in the project. Even in the face of a widely dispersed team, the InfoStrength SES delivers functionality that creates a working collaborative team whose members are accountable to each other." said Russ King, Senior Account Executive with InfoStrength.

About InfoStrength

InfoStrength, Inc., a minority owned business headquartered in Raleigh, NC, is a proven leader of information management and regulatory-compliant business strategy and applications. InfoStrengths applications address FDA 21 CFR Part 11 and HIPAA requirements, are configurable to meet clients internal quality standards, and undergo a managed lifecycle in compliance with CMM and ISO standards. InfoStrength is the developer of the InfoStrength Smart Enterprise Suite. Visit www.infostrength.com for more information.

About Clinical Trial Services

Clinical Trial Services (CTS) specializes in the preparation and management of clinical trial supplies for leading pharmaceutical and biotech companies. CTS services extend from phase one to four, including child resistant supplies for the US market and it has developed automated systems to expedite the labeling verification and distribution of supplies. CTS is a member of the Almac Sciences family of companies. Almac Sciences and its affiliated companies provide pharmaceutical services across a wide range of activities from drug discovery, process development, clinical trials through to the manufacture and packaging of commercial products. Operations are based in USA (Pennsylvania, North Carolina and California) and UK, Craigavon and Maidenhead. CSS, CTS, ICTI and PDMS were purchased from Galen Holdings plc over the past 18 months. Visit www.cts-global.com for more information.

###